Bioregenx (BRGX) Total Liabilities (2021 - 2026)

Bioregenx's Total Liabilities history runs 6 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 20.51% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (up 20.51% YoY), while the FY2025 annual figure was $4.9 million, up 27.28% from the prior year.
• Total Liabilities was $4.9 million for Q1 2026 at Bioregenx, down from $4.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $4.9 million in Q4 2025 to a low of $101553.0 in Q1 2022.
• Historically, Total Liabilities has averaged $2.5 million across 5 years, with a median of $3.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities increased 10.9% in 2023, then jumped 1480.07% in 2024.
• A 5-year view of Total Liabilities shows it stood at $260691.0 in 2022, then jumped by 1026.69% to $2.9 million in 2023, then jumped by 32.36% to $3.9 million in 2024, then gained by 27.28% to $4.9 million in 2025, then fell by 1.57% to $4.9 million in 2026.
• The last three Total Liabilities figures came in at $4.9 million (Q1 2026), $4.9 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.